The role of sibutramine in weight reduction
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F13%3A43874772" target="_blank" >RIV/60162694:G44__/13:43874772 - isvavai.cz</a>
Výsledek na webu
<a href="http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=3334&category_id=103&option=com_virtuemart&vmcchk=1&Itemid=1" target="_blank" >http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=3334&category_id=103&option=com_virtuemart&vmcchk=1&Itemid=1</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4149/BLL_2013_034" target="_blank" >10.4149/BLL_2013_034</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The role of sibutramine in weight reduction
Popis výsledku v původním jazyce
The effectiveness of pharmacologic support with sibutramine along with the preservation of dietary and regimen measures is shown in a group of long-term treated patients at the Metabolic Clinic of the University Hospital in Hradec Králové. In ambulatorypatients, basic anthropometric parameters as body weight, BMI, waist circumference and the total amount of adipose tissue were compared before substitution with 10 mg sibutramine and after a four-month therapy. This group included 94 patients who were administered the same dose of sibutramine for the whole period of time. This group consisted of 37 men and 57 women. After a four-month therapy with sibutramine there was a mean reduction in weight by 7.9+-3.8 kg in the monitored group of patients. Their BMI was reduced by 2.3+-1.5 kg/height2 and the waist circumference by 4.4+-3.8 cm. The decrease in the percentage of the total body lipid was 2.9 %. Despite a surprising decision of the European Drug Agency to suspend the registration of s
Název v anglickém jazyce
The role of sibutramine in weight reduction
Popis výsledku anglicky
The effectiveness of pharmacologic support with sibutramine along with the preservation of dietary and regimen measures is shown in a group of long-term treated patients at the Metabolic Clinic of the University Hospital in Hradec Králové. In ambulatorypatients, basic anthropometric parameters as body weight, BMI, waist circumference and the total amount of adipose tissue were compared before substitution with 10 mg sibutramine and after a four-month therapy. This group included 94 patients who were administered the same dose of sibutramine for the whole period of time. This group consisted of 37 men and 57 women. After a four-month therapy with sibutramine there was a mean reduction in weight by 7.9+-3.8 kg in the monitored group of patients. Their BMI was reduced by 2.3+-1.5 kg/height2 and the waist circumference by 4.4+-3.8 cm. The decrease in the percentage of the total body lipid was 2.9 %. Despite a surprising decision of the European Drug Agency to suspend the registration of s
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FB - Endokrinologie, diabetologie, metabolismus, výživa
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2013
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Bratislava Medical Journal-Bratislavske Lekarske Listy
ISSN
0006-9248
e-ISSN
—
Svazek periodika
114
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
SK - Slovenská republika
Počet stran výsledku
3
Strana od-do
155-157
Kód UT WoS článku
000315758300011
EID výsledku v databázi Scopus
—